Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àü¸³¼±¾Ï¼¼Æ÷ÁÖÀÇ ¼ºÀå¿¡ ¹ÌÄ¡´Â Synthetic Tyrosine Kinase Inhibitor(zM260603)ÀÇ ¿µÇâ: ¾Èµå·ÎÁ¨ ÀÇÁ¸¼º°ú Bcl-2 Ç¥Çö¿¡ µû¸¥ Â÷ÀÌ Effect of Synthetic Tyrosine Kinase Inhibitor(ZM260603) on the Growth of Prostate Cancer Cell Lines: Differences According to Androgen Dependency and Bcl-2 Expression

´ëÇѺñ´¢±â°úÇÐȸÁö 1999³â 40±Ç 11È£ p.1487 ~ 1492
¾Èµ¿È¯, Á¤ÇöÁ÷, À̵¿Çö, Á¶Àº¼Û,
¼Ò¼Ó »ó¼¼Á¤º¸
¾Èµ¿È¯ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Á¤ÇöÁ÷ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
À̵¿Çö (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¶Àº¼Û (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

[ÃʷϾøÀ½:No abstract]

Å°¿öµå

Tyrosine kinase inhibitor; Prostate cancer cell line; Bcl-2 expression; Androgen-dependency;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS